Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 19, 2019

SELL
$123.4 - $148.55 $1,110 - $1,336
-9 Closed
0 $0
Q2 2018

Jul 26, 2018

BUY
$102.37 - $117.25 $818 - $938
8 Added 800.0%
9 $1,000
Q1 2018

Apr 18, 2018

SELL
$98.19 - $115.2 $25,038 - $29,376
-255 Reduced 99.61%
1 $0
Q4 2017

Jan 18, 2018

BUY
$100.43 - $118.09 $25,710 - $30,231
256
256 $28,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.